Nothing Special   »   [go: up one dir, main page]

ITMI20032338A1 - Composti feniltetrazolici. - Google Patents

Composti feniltetrazolici.

Info

Publication number
ITMI20032338A1
ITMI20032338A1 IT002338A ITMI20032338A ITMI20032338A1 IT MI20032338 A1 ITMI20032338 A1 IT MI20032338A1 IT 002338 A IT002338 A IT 002338A IT MI20032338 A ITMI20032338 A IT MI20032338A IT MI20032338 A1 ITMI20032338 A1 IT MI20032338A1
Authority
IT
Italy
Prior art keywords
phenyltetrazolic
compounds
angiotensin
antagonists
intermediates
Prior art date
Application number
IT002338A
Other languages
English (en)
Inventor
Pietro Allegrini
Mauro Ercoli
Domenico Magrone
Original Assignee
Dinamite Dipharma S P A In Forma A Bbreviata Diph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dinamite Dipharma S P A In Forma A Bbreviata Diph filed Critical Dinamite Dipharma S P A In Forma A Bbreviata Diph
Priority to IT002338A priority Critical patent/ITMI20032338A1/it
Priority to AT04027599T priority patent/ATE373645T1/de
Priority to ES04027599T priority patent/ES2273617T3/es
Priority to PL04027599T priority patent/PL1555260T3/pl
Priority to PT04027599T priority patent/PT1555260E/pt
Priority to DE602004009030T priority patent/DE602004009030T2/de
Priority to EP04027599A priority patent/EP1555260B1/en
Priority to US10/995,135 priority patent/US7345072B2/en
Priority to JP2004340068A priority patent/JP2005162751A/ja
Publication of ITMI20032338A1 publication Critical patent/ITMI20032338A1/it
Priority to US12/021,313 priority patent/US20080119657A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT002338A 2003-11-28 2003-11-28 Composti feniltetrazolici. ITMI20032338A1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT002338A ITMI20032338A1 (it) 2003-11-28 2003-11-28 Composti feniltetrazolici.
AT04027599T ATE373645T1 (de) 2003-11-28 2004-11-19 Phenyltetrazol-verbindungen
ES04027599T ES2273617T3 (es) 2003-11-28 2004-11-19 Compuestos de feniltetrazol.
PL04027599T PL1555260T3 (pl) 2003-11-28 2004-11-19 Związki fenylotetrazolu
PT04027599T PT1555260E (pt) 2003-11-28 2004-11-19 Compostos de feniltetrazol
DE602004009030T DE602004009030T2 (de) 2003-11-28 2004-11-19 Phenyltetrazolverbindungen
EP04027599A EP1555260B1 (en) 2003-11-28 2004-11-19 Phenyltetrazole compounds
US10/995,135 US7345072B2 (en) 2003-11-28 2004-11-24 Phenyltetrazole compounds
JP2004340068A JP2005162751A (ja) 2003-11-28 2004-11-25 フェニルテトラゾール化合物
US12/021,313 US20080119657A1 (en) 2003-11-28 2008-01-29 Phenyltetrazole compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002338A ITMI20032338A1 (it) 2003-11-28 2003-11-28 Composti feniltetrazolici.

Publications (1)

Publication Number Publication Date
ITMI20032338A1 true ITMI20032338A1 (it) 2005-05-29

Family

ID=34611237

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002338A ITMI20032338A1 (it) 2003-11-28 2003-11-28 Composti feniltetrazolici.

Country Status (9)

Country Link
US (2) US7345072B2 (it)
EP (1) EP1555260B1 (it)
JP (1) JP2005162751A (it)
AT (1) ATE373645T1 (it)
DE (1) DE602004009030T2 (it)
ES (1) ES2273617T3 (it)
IT (1) ITMI20032338A1 (it)
PL (1) PL1555260T3 (it)
PT (1) PT1555260E (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1993355A (zh) * 2004-09-02 2007-07-04 特瓦制药工业有限公司 奥美沙坦酯的纯化方法
DE102004060699A1 (de) * 2004-12-16 2006-06-22 Ratiopharm Gmbh Verfahren zur Herstellung von Candesartan
WO2006067216A2 (en) * 2004-12-22 2006-06-29 Enantia, S. L. Intermediate compounds for the preparation of an angiotensin ii receptor and process for the preparation of valsartan
CN101094850A (zh) 2005-01-03 2007-12-26 特瓦制药工业有限公司 具有较低水平杂质的奥美沙坦酯
US20070117987A1 (en) * 2005-07-05 2007-05-24 Viviana Braude Process for preparing valsartan
EP1816131A1 (en) * 2006-02-06 2007-08-08 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of olmesartan medoxomil
EP1910343B1 (en) * 2005-07-29 2014-10-29 Krka Process for the preparation of olmesartan medoxomil
WO2007071750A1 (en) * 2005-12-22 2007-06-28 Enantia, S.L. Intermediates and processes for the preparation of valsartan
ES2300175B1 (es) * 2006-02-14 2009-06-08 Inke, S.A. Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo.
ITMI20061848A1 (it) * 2006-09-27 2008-03-28 Dipharma Spa Procedimento per la preparazione di composti feniltetrazolici
SI2176253T1 (sl) * 2007-08-08 2012-02-29 Lek Pharmaceuticals D.D. Postopek priprave ali čiščenja olmesartan medoksomila ali hidrohalidne soli olmesartan medoksomila
CA2762846A1 (en) 2009-05-20 2010-11-25 Ranbaxy Laboratories Limited Process for the preparation of olmesartan medoxomil
KR101117128B1 (ko) * 2009-06-02 2012-03-14 한국화학연구원 페닐테트라졸 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 골다공증 또는 비만의 예방 또는 치료용 약학적 조성물
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof
CN102675294A (zh) * 2012-05-17 2012-09-19 浙江天宇药业股份有限公司 一种合成氯沙坦及其中间体的方法
CN105001209A (zh) * 2015-06-29 2015-10-28 千辉药业（安徽）有限责任公司 一种厄贝沙坦的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5412102A (en) * 1994-05-27 1995-05-02 Syntex (U.S.A.) Inc. Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid
TW409125B (en) * 1996-04-22 2000-10-21 Novartis Ag Antivirally active heterocyclic azahexane derivatives
ATE314097T1 (de) * 1996-10-28 2006-01-15 Amersham Health As Kontrastmittel
JP2002145770A (ja) * 2000-08-30 2002-05-22 Sankyo Co Ltd 心不全の予防又は治療のための医薬組成物

Also Published As

Publication number Publication date
ES2273617T3 (es) 2008-03-16
DE602004009030T2 (de) 2008-06-12
DE602004009030D1 (de) 2007-10-31
US7345072B2 (en) 2008-03-18
PT1555260E (pt) 2007-12-04
EP1555260B1 (en) 2007-09-19
EP1555260A1 (en) 2005-07-20
JP2005162751A (ja) 2005-06-23
US20080119657A1 (en) 2008-05-22
PL1555260T3 (pl) 2008-02-29
ES2273617T1 (es) 2007-05-16
ATE373645T1 (de) 2007-10-15
US20050119488A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
ATE373645T1 (de) Phenyltetrazol-verbindungen
LTPA2020507I1 (lt) 2,4-Pirimidindiamino junginių provaistai ir jų panaudojimas
EA200501333A1 (ru) 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ
DE602004028359D1 (de) Reinigung von biologisch produziertem 1,3-propandiol
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
ATE461188T1 (de) Verstärker von glutamat-rezeptoren
ATE419250T1 (de) 2-cyanopyrrolidincarbonsäureamide als dipeptidylpeptidase-iv-inhibitoren
CL2013002895A1 (es) Compuestos derivados de 7,8-dihidro-5h-pteridin-6-ona, utiles como intermediarios en la sintesis de compuestos derivados de pteridinona (divisional de la solicitud 3123-2005).
DE502005009089D1 (de) 1-methyl-3-trifluormethyl-pyrazol-4-carbonsäure-(ortho-phenyl)-anilide und ihre verwendung als fungizid
ATE481987T1 (de) Verfahren zur radiofluoridierung von biologisch aktiven vektoren
DE602005013819D1 (de) Pyridincarbonsäureamidderivate zur verwendung als antikrebsmittel
ATE345683T1 (de) Malonsäuerenitril-verbindungen und ihre verwendung als pestizide
DE60315146D1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
IL178156A0 (en) Intermediates for the preparation of pramipexole
ATE374768T1 (de) Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren
EA200700702A1 (ru) Аналоги локсапина и способы их применения
MA28698B1 (fr) Dicetopiperazines substituees utilisees comme antagonistes des oxytocines
DE50305374D1 (de) Neue prodrugs von 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(n -2-pyridil-n-2-hydroxycarbonylethyl)-amid, ihre herstellung und ihre verwendung als arzneimittel
ATE413392T1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
MA28846B1 (fr) Composition biologiquement active
DE502006003030D1 (de) Verwendung von inhibitoren des na+/h+ austauschers, subtyp 5 (nhe5) zur gedächtnisverbesserung
ATE390427T1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
CO5540291A2 (es) Benzamidoacetonitrilos y su uso como antiparasitarios
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe
DE602004010530D1 (de) Verfahren zur herstellung von phenyltetrazolderivaten